5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | NEUTRAL | NEUTRAL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 6.89▼ | 6.89▼ | 6.87▲ | 7.17▼ | 6.51▲ |
MA10 | 6.89▼ | 6.87▲ | 6.88▲ | 6.87▲ | 6.66▲ |
MA20 | 6.89▼ | 6.88▲ | 7.01▼ | 6.56▲ | 6.70▲ |
MA50 | 6.87▲ | 7.11▼ | 7.11▼ | 6.71▲ | 7.57▼ |
MA100 | 6.88▲ | 7.07▼ | 6.66▲ | 6.77▲ | 7.61▼ |
MA200 | 7.04▼ | 6.63▲ | 6.65▲ | 7.51▼ | 7.31▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.003▼ | 0.020▲ | -0.016▼ | 0.088▲ | 0.052▲ |
RSI | 49.769▼ | 43.983▼ | 42.077▼ | 54.246▲ | 49.193▼ |
STOCH | 27.597 | 79.441 | 48.166 | 81.849▲ | 35.649 |
WILL %R | -75.000▼ | -36.538 | -68.269 | -39.048 | -39.048 |
CCI | -64.000 | 51.129 | -6.992 | 31.864 | 120.512▲ |
Tuesday, August 12, 2025 11:16 AM
As the S&P 500 and Nasdaq Composite reach new all-time highs following a favorable July CPI report, investor optimism is buoyed by expectations of potential Federal Reserve rate cuts. In this ...
|
Tuesday, August 12, 2025 05:22 AM
Q2 2025 Earnings Call Transcript August 8, 2025 Operator: Greetings, and welcome to the Viemed Healthcare Second Quarter 2025 Earnings Call. [Operator Instructions] As a reminder, this conference is ...
|
Friday, August 08, 2025 12:36 AM
Viemed Healthcare Inc (VMD) reports a 14.7% revenue increase, driven by organic growth and strategic acquisitions, while raising full-year guidance.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 7.05 | 7.05 | 6.711 | 6.89 | 313,800 |
14/08/25 | 7.26 | 7.33 | 6.781 | 6.89 | 304,115 |
13/08/25 | 7.48 | 7.505 | 7.26 | 7.33 | 307,100 |
12/08/25 | 7.34 | 7.46 | 7.23 | 7.44 | 355,700 |
11/08/25 | 7.18 | 7.43 | 7.155 | 7.29 | 425,800 |
08/08/25 | 6.96 | 7.155 | 6.96 | 7.10 | 737,834 |
07/08/25 | 6.76 | 7.13 | 6.66 | 6.96 | 486,300 |
06/08/25 | 6.33 | 6.50 | 6.2982 | 6.45 | 438,091 |
05/08/25 | 6.07 | 6.33 | 6.07 | 6.32 | 411,900 |
04/08/25 | 5.97 | 6.10 | 5.96 | 6.07 | 319,100 |
|
|
||||
|
|
||||
|
|